Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six

Virology

Volumn 234, Issue 1, 1997, Pages 74-83

  Durbin, Anna P ^a   Siew, Jeffrey W ^a   Murphy, Brian R ^a   Collins, Peter L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GENOME; NONHUMAN; PARAINFLUENZA VIRUS 3; PLASMID; PRIORITY JOURNAL; RNA REPLICATION; RNA TRANSCRIPTION;

BACTERIA (MICROORGANISMS); FELIS CATUS; HUMAN PARAINFLUENZA VIRUS 3; VACCINIA; VACCINIA VIRUS;

EID: 0031582648     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8633     Document Type: Article

References (36)

1. Baker S., Moyer S. Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication. J. Virol. 62:1988;834-838.
2. Cadd T., Garcin D., Tapparel C., Itoh M., Homma M., Roux L., Curran J., Kolakofsky D. The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J. Virol. 70:1996;5067-5074.
3. Calain P., Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:1993;4822-4830.
4. Calain P., Roux L. Functional characterization of the genomic and antigenomic promoters of Sendai virus. Virology. 212:1995;163-173.
5. Chomczynski P. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal. Biochem. 201:1992;134-139.
6. Collins P. L., Chanock R. M., McIntosh K. Parainfluenza viruses. Virology. 1996a;Raven Press, New York. p. 1205-1242.
7. Collins P. L., Hill M. G., Cristina J., Grosfeld H. Transcriptional elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc. Natl. Acad. Sci. USA. 93:1996b;81-85.
8. Conzelmann K.-K. Genetic manipulation of non-segmented negative strand RNA viruses. J. Gen. Virol. 77:1996;381-389.
9. Curran J., Boeck R., Kolakofsky D. The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via RNA editing. EMBO J. 10:1991;3079-3085.
10. De B. P., Banerjee A. K. Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. Virology. 196:1993;344-348.
11. Dimock K., Collins P. L. Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3. J. Virol. 67:1993;2772-2778.
12. Elroy-Stein O., Fuerst T. R., Moss B. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid system. Proc. Natl. Acad. Sci. USA. 86:1989;6126-6130.
13. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
14. Galinski M. S. Paramyxoviridae: Transcription and replication. Adv. Virus Res. 39:1991;129-162.
15. Galinski M. A., Mink M. A., Pons M. W. Molecular cloning and sequence analysis of the human parainfluenza 3 virus gene encoding the L protein. Virology. 165:1988;499-510.
16. Galinski M. A., Troy R. M., Banerjee A. K. RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology. 186:1992;543-550.
17. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
18. Grosfeld H., Hill M. G., Collins P. L. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P and L proteins; Transcription also occurred under these conditions but required RSV superinfection to be fully authentic. J. Virol. 69:1995;5677-5686.
19. Harty R. N., Palese P. Mutations within noncoding terminal sequences of model RNAs of Sendai virus: Influence on reporter gene expression. J. Virol. 69:1995;5128-5131.
20. Hausmann S., Jacques J. P., Kolakofsky D. Paramyxovirus RNA editing and the requirement for hexamer genome length. RNA. 2:1996;1033-1045.
21. Jacques J.-P., Hausmann S., Kolakofsky D. Paramyxovirus mRNA editing leads to G deletions as well as insertions. EMBO J. 13:1994;5496-5503.
22. Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:1997;578-587.
23. Lamb R. A., Kolakofsky D. Paramyxoviridae: Fields Virology. 1996;Raven Press, New York.
24. Murphy B. R., Prince G. A., Collins P. L., Van Wyke Coelingh K., Olmsted R. A., Spriggs M. K., Parrott R. H., Kim H., Brandt C. D., Chanock R. M. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. Virus Res. 11:1988;1-15.
25. Murphy B. R., Hall S. L., Kulkarni A. B., Crowe J. E. Jr., Collins P. L., Connors M., Karron R. A., Chanock R. M. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:1994;13-36.
26. Palese P., Zheng H., Engelhardt O. G., Pleschka S., Garcia-Sastre A. Negative-strand viruses: Genetic engineering and applications. Proc. Natl. Acad. Sci. USA. 93:1996;11354-11358.
27. Pattnaik A., Ball L. A., LeGrone A. W., Wertz G. W. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell. 69:1992;1011-1020.
28. Pelet T., Curran J., Kolakofsky D. The P gene of bovine parainfluenza virus type 3 expresses all three reading frames from a single mRNA editing site. EMBO J. 10:1991;443-448.
29. Pelet T., Delenda C., Gubbay O., Garcin D., Kolakofsky D. Partial characterization of a Sendai virus replication promoter and the rule of six. Virology. 224:1996;405-414.
30. Perrotta A. T., Been M. D. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature. 350:1991;434-436.
31. Samal S. K., Collins P. L. RNA replication by a respiratory syncytial virus minigenome does not obey the "rule of six" and retains a nonviral trinucleotide extension at the leader end. J. Virol. 70:1996;5075-5082.
32. Sidhu M. S., Chan J., Kaelin K., Spielhofer P., Radecke F., Schneider H., Masurekar M., Dowling P. C., Billeter M. A., Udem S. A. Rescue of synthetic measles virus minireplicons: Measles genomic termini direct efficient expression and propagation of a reporter gene. Virology. 208:1995;800-807.
33. Spriggs M. K., Collins P. L. Human parainfluenza virus type 3: Messenger RNAs, polypeptide coding assignments, intergenic sequences and genetic map. J. Virol. 59:1986;646-654.
34. Stokes A., Tierney E. L., Murphy B. R., Hall S. L. The complete sequence of the JS strain of human parainfluenza virus type 3: Comparison with the Wash/47885/57 prototype strain. Virus Res. 25:1992;91-103.
35. Thomas S. M., Lamb R. A., Paterson R. G. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell. 54:1988;891-902.
36. Yuen L., Moss B. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. USA. 84:1987;6417-6421.